Neurosearch (NEUR)

All online trades £12.50 plus an annual Management Fee of £35 & VAT with Selftrade. Apply

Dk 107.50
   
  • 52 Week High: Dk278.50
  • 52 Week Low: Dk63.00
  • Currency: Denmark Kroner
  • Shares Issued: 24.29m
  • Market Cap: Dk2,610.96m

Neurosearch Overview

NeuroSearch is a Scandinavian biopharmaceutical company that invents, develops and markets novel drugs to treat diseases of the central nervous system and selected somatic diseases. The Company's products are used in the treatment of disease such as Alzheimer, Parkinson, Huntington, psychoses, depression, ADHD, and epilepsy.

3 Month Chart

3 Month Chart

1 Year Chart

1 Year Chart

Financials

Latest F'cast
Div Yield 0.0%
Div Cover n/a
Op Mrgn -473.1%
ROCE n/a
Latest F'cast
P/E n/a
PEG n/a
Pr/Revenue n/a
Pr/Book n/a
Latest F'cast
Revenue -18.0%
PBT n/a
EPS n/a
DPS n/a

Neurosearch Fundamentals

Year Ending Revenue (Dkm) Pre-tax (Dkm) EPS P/E PEG EPS Grth. Div Yield
31-Dec-06 66.34 (212.17) (24.17)Dk n/a n/a n/a n/a 0.0%
31-Dec-07 115.21 (294.73) (21.17)Dk n/a n/a n/a n/a 0.0%
31-Dec-08 66.77 (415.92) (24.47)Dk n/a n/a n/a n/a 0.0%
31-Dec-09 84.58 (331.20) (16.39)Dk n/a n/a n/a n/a 0.0%
31-Dec-10 69.34 (306.25) (10.56)Dk n/a n/a n/a n/a 0.0%

Neurosearch Forecasts

Neurosearch Forecasts data is not available for this company.

Copyright © 2012 FactSet Research Systems Inc. All rights reserved.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

Note 2: Forecast figures based on normalised accounts.

 

Neurosearch Market Data

Currency Denmark Kroner
% Change 1.42 %
52 Week High Dk278.50
52 Week Low Dk63.00
Shares Issued 24.29m
Market Cap Dk2,610.96m

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 4
Sell 0
Strong Sell 0
Total 5
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Top of Page